INS and type 2 diabetes mellitus: The purchase of glucose-lowering drugs other than insulin during pregnancy was not adjusted for because only 0.38% of mothers with insulin-treated pregestational diabetes, 0.43% of mothers with type 2 diabetes, 0.32% of mothers with gestational diabetes, and 0.28% of mothers without diabetes purchased such drugs.